Developing Therapies for Chronic Diseases

Some of the most challenging diseases of our time — atherosclerotic, neurodegenerative, metabolic, autoimmune diseases, etc. — may ride the same steed: inflammation. Inflammation, by definition, should be good. It is the way our body heals itself after injury. But chronic, unchecked, continually ramped-up inflammation leads to the opposite: chronic disorders in many forms.

Today, we discuss the work of Promakhos Therapeutics, a biotech startup that develops therapies for chronic inflammatory diseases. A duo of medical researchers from Harvard and MIT, backed by Y Combinator, with a mission to help our bodies control inflammation and heal. With Katerina Chatzi, CEO and founder, we talked about:

Συνέχεια  εδώ


Σχετικά Άρθρα